GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders

Rosa Maria Serio, Michelangelo Auteri, Josipa Vlainić, Maja Jazvinšćak Jembrek

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Among them benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action.Conclusion: The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.
Original languageEnglish
Pages (from-to)4003-4011
Number of pages9
JournalCURRENT PHARMACEUTICAL DESIGN
Volume23
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders'. Together they form a unique fingerprint.

  • Cite this